Citations to this article
Abstract
The emergence of SARS-CoV-2 has created an international health crisis, and small animal models mirroring SARS-CoV-2 human disease are essential for medical countermeasure (MCM) development. Mice are refractory to SARS-CoV-2 infection owing to low-affinity binding to the murine angiotensin-converting enzyme 2 (ACE2) protein. Here, we evaluated the pathogenesis of SARS-CoV-2 in male and female mice expressing the human ACE2 gene under the control of the keratin 18 promoter (K18). In contrast to nontransgenic mice, intranasal exposure of K18-hACE2 animals to 2 different doses of SARS-CoV-2 resulted in acute disease, including weight loss, lung injury, brain infection, and lethality. Vasculitis was the most prominent finding in the lungs of infected mice. Transcriptomic analysis from lungs of infected animals showed increases in transcripts involved in lung injury and inflammatory cytokines. In the low-dose challenge groups, there was a survival advantage in the female mice, with 60% surviving infection, whereas all male mice succumbed to disease. Male mice that succumbed to disease had higher levels of inflammatory transcripts compared with female mice. To our knowledge, this is the first highly lethal murine infection model for SARS-CoV-2 and should be valuable for the study of SARS-CoV-2 pathogenesis and for the assessment of MCMs.
Authors
Joseph W. Golden, Curtis R. Cline, Xiankun Zeng, Aura R. Garrison, Brian D. Carey, Eric M. Mucker, Lauren E. White, Joshua D. Shamblin, Rebecca L. Brocato, Jun Liu, April M. Babka, Hypaitia B. Rauch, Jeffrey M. Smith, Bradley S. Hollidge, Collin Fitzpatrick, Catherine V. Badger, Jay W. Hooper
Citation information
Citations to this article in year 2022 (44)
| Title and authors | Publication | Year |
|---|---|---|
|
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
Naveenchandra Suryadevara, Andrea R Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E Chen, James Brett Case, Kevin J Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin Doranz, Summer Diaz, Laura S Handal, Robert H Carnahan, Michael Diamond, Ivelin Georgiev, James E. Crowe Jr. |
Journal of Clinical Investigation | 2022 |
|
Immune responses to human respiratory coronaviruses infection in mouse models
Z Zhuang, D Liu, J Sun, F Li, J Zhao |
Current Opinion in Virology | 2022 |
|
Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice
S Belouzard, A Machelart, V Sencio, T Vausselin, E Hoffmann, N Deboosere, Y Rouillé, L Desmarets, K Séron, A Danneels, C Robil, L Belloy, C Moreau, C Piveteau, A Biela, A Vandeputte, S Heumel, L Deruyter, J Dumont, F Leroux, I Engelmann, E Alidjinou, D Hober, P Brodin, T Beghyn, F Trottein, B Deprez, J Dubuisson, V Menachery |
PLoS pathogens | 2022 |
|
Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations
G Cárdenas, G Fragoso, E Sciutto |
Current Opinion in Pharmacology | 2022 |
|
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
E Winkler, R Chen, F Alam, S Yildiz, J Case, M Uccellini, M Holtzman, A Garcia-Sastre, M Schotsaert, M Diamond, S Schultz-Cherry |
Journal of virology | 2022 |
|
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2
J Golden, R Li, C Cline, X Zeng, E Mucker, A Fuentes-Lao, K Spik, J Williams, N Twenhafel, N Davis, J Moore, S Stevens, E Blue, A Garrison, D Larson, R Stewart, M Kunzler, Y Liu, Z Wang, J Hooper, H Batra, M Mahalingam |
mBio | 2022 |
|
SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models
B Stolp, M Stern, I Ambiel, K Hofmann, K Morath, L Gallucci, M Cortese, R Bartenschlager, A Ruggieri, F Graw, M Rudelius, O Keppler, O Fackler |
Cell Reports | 2022 |
|
GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19
Huntington Potter, Lon Kendall, Timothy Boyd, Stefan Sillau, Angela Bosco-Lauth, Neil Markham, Derek Fong, Penny Clarke, Kenneth Tyler |
Research square | 2022 |
|
SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways
H Rothan, P Kumari, S Stone, J Natekar, K Arora, T Auroni, M Kumar |
Pathogens | 2022 |
|
Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
Y Levy, R Alcalay, A Zvi, E Makdasi, E Peretz, T Noy-Porat, T Chitlaru, M Mandelboim, O Mazor, R Rosenfeld |
Human vaccines | 2022 |
|
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
M Carossino, D Kenney, A OConnell, P Montanaro, A Tseng, H Gertje, K Grosz, M Ericsson, B Huber, S Kurnick, S Subramaniam, T Kirkland, J Walker, K Francis, A Klose, N Paragas, M Bosmann, M Saeed, U Balasuriya, F Douam, N Crossland |
Viruses | 2022 |
|
The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
J Domizio, M Gulen, F Saidoune, V Thacker, A Yatim, K Sharma, T Nass, E Guenova, M Schaller, C Conrad, C Goepfert, L de Leval, C von Garnier, S Berezowska, A Dubois, M Gilliet, A Ablasser |
Nature | 2022 |
|
Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro
Q Ma, B Lei, R Chen, B Liu, W Lu, H Jiang, Z Chen, X Guo, Y Wang, L Zhang, Q Chen, X Li, Z Yang |
Chinese medicine | 2022 |
|
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
E Cecon, D Fernandois, N Renault, C Coelho, J Wenzel, C Bedart, C Izabelle, S Gallet, S Poder, B Klonjkowski, M Schwaninger, V Prevot, J Dam, R Jockers |
Cellular and Molecular Life Sciences | 2022 |
|
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Z Chong, C Karl, P Halfmann, Y Kawaoka, E Winkler, S Keeler, M Holtzman, J Yu, M Diamond |
Cell Reports | 2022 |
|
Oral SARS-CoV-2 Inoculation Causes Nasal Viral Infection Leading to Olfactory Bulb Infection: An Experimental Study
Ueha R, Ito T, Furukawa R, Kitabatake M, Ouji-Sageshima N, Ueha S, Koyama M, Uranaka T, Kondo K, Yamasoba T |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan
Liu X, Mostafavi H, Ng WH, Freitas JR, King NJ, Zaid A, Taylor A, Mahalingam S |
mBio | 2022 |
|
A GABA-receptor agonist reduces disease severity, viral load, and death in SARS-CoV-2-infected mice
Jide Tian, Barbara Dillion, Jill Henley, Lucio Comai, Daniel Kaufman |
Frontiers in immunology | 2022 |
|
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Chen M, Pekosz A, Villano JS, Shen W, Zhou R, Kulaga H, Li Z, Beck SE, Witwer KW, Mankowski JL, Ramanathan M Jr, Rowan NR, Lane AP |
2022 | |
|
Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2
Rodrigues P, Costa RS, Henriques R |
Computers in Biology and Medicine | 2022 |
|
Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes
Syenina A, Gan ES, Toh JZ, de Alwis R, Lin LZ, Tham CY, Yee JX, Leong YS, Sam H, Cheong C, Teh YE, Wee IL, Ng DH, Chan KR, Sim JX, Kalimuddin S, Ong EZ, Low JG, Ooi EE |
PLoS Biology | 2022 |
|
Immune-Mediated Mechanisms of COVID-19 Neuropathology
Dunai C, Collie C, Michael BD |
Frontiers in neurology | 2022 |
|
Spherical nucleic acids as an infectious disease vaccine platform
Teplensky MH, Distler ME, Kusmierz CD, Evangelopoulos M, Gula H, Elli D, Tomatsidou A, Nicolaescu V, Gelarden I, Yeldandi A, Batlle D, Missiakas D, Mirkin CA |
Proceedings of the National Academy of Sciences | 2022 |
|
Defining the risk of SARS-CoV-2 variants on immune protection
DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon AC, Boritz EA, Bratt DL, Bricker TL, Brown L, Buchser WJ, Carreño JM, Cohen-Lavi L, Darling TL, Davis-Gardner ME, Dearlove BL, Di H, Dittmann M, Doria-Rose NA, Douek DC, Drosten C, Edara VV, Ellebedy A, Fabrizio TP, Ferrari G, Florence WC, Fouchier RA, Franks J, García-Sastre A, Godzik A, Gonzalez-Reiche AS, Gordon A, Haagmans BL, Halfmann PJ, Ho DD, Holbrook MR, Huang Y, James SL, Jaroszewski L, Jeevan T, Johnson RM, Jones TC, Joshi A, Kawaoka Y, Kercher L, Koopmans MP, Korber B, Koren E, Koup RA, LeGresley EB, Lemieux JE, Liebeskind MJ, Liu Z, Livingston B, Logue JP, Luo Y, McDermott AB, McElrath MJ, Meliopoulos VA, Menachery VD, Montefiori DC, Mühlemann B, Munster VJ, Munt JE, Nair MS, Netzl A, Niewiadomska AM, O\u2019Dell S, Pekosz A, Perlman S, Pontelli MC, Rockx B, Rolland M, Rothlauf PW, Sacharen S, Scheuermann RH, Schmidt SD, Schotsaert M, Schultz-Cherry S, Seder RA, Sedova M, Sette A, Shabman RS, Shen X, Shi PY, Shukla M, Simon V, Stumpf S, Sullivan NJ, Thackray LB, Theiler J, Thomas PG, Trifkovic S, Türeli S, Turner SA, Vakaki MA, van Bakel H, VanBlargan LA, Vincent LR, Wallace ZS, Wang L, Wang M, Wang P, Wang W, Weaver SC, Webby RJ, Weiss CD, Wentworth DE, Weston SM, Whelan SP, Whitener BM, Wilks SH, Xie X, Ying B, Yoon H, Zhou B, Hertz T, Smith DJ, Diamond MS, Post DJ, Suthar MS |
Nature | 2022 |
|
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection.
Hassler L, Wysocki J, Gelarden I, Sharma I, Tomatsidou A, Ye M, Gula H, Nicoleascu V, Randall G, Pshenychnyi S, Khurram N, Kanwar Y, Missiakas D, Henkin J, Yeldandi A, Batlle D |
Journal of the American Society of Nephrology : JASN | 2022 |
|
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
Dedoni S, Avdoshina V, Camoglio C, Siddi C, Fratta W, Scherma M, Fadda P |
Molecules (Basel, Switzerland) | 2022 |
|
Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection.
Sheikh-Mohamed S, Sanders EC, Gommerman JL, Tal MC |
Immunological Reviews | 2022 |
|
BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.
Manangeeswaran M, Ireland DDC, Thacker SG, Lee HN, Kelley-Baker L, Lewkowicz AP, Rothlauf PW, Cornejo Pontelli M, Bloyet LM, Eckhaus MA, Mendoza MI, Whelan S, Verthelyi D |
Frontiers in immunology | 2022 |
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review.
Brosseau LM, Escandón K, Ulrich AK, Rasmussen AL, Roy CJ, Bix GJ, Popescu SV, Moore KA, Osterholm MT |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022 |
|
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
Liu S, Selvaraj P, Sangare K, Luan B, Wang TT |
Cell Reports | 2022 |
|
The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
Chen F, Chen Y, Wang Y, Ke Q, Cui L |
Translational Neurodegeneration | 2022 |
|
Obesity and metabolic dysfunction drive sex-associated differential disease profiles in hACE2-mice challenged with SARS-CoV-2.
Lee KS, Russ BP, Wong TY, Horspool AM, Winters MT, Barbier M, Bevere JR, Martinez I, Damron FH, Cyphert HA |
iScience | 2022 |
|
Animal Models of COVID-19: Transgenic Mouse Model
Park JG, Pino PA, Akhter A, Alvarez X, Torrelles JB, Martinez-Sobrido L |
Methods in molecular biology (Clifton, N.J.) | 2022 |
|
COVID-19 and the Kidney: Recent Advances and Controversies
Menez S, Parikh CR |
Seminars in Nephrology | 2022 |
|
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia.
Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E, Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J |
Nature Communications | 2022 |
|
Characteristics of animal models for COVID-19.
Qi F, Qin C |
2022 | |
|
Evidence for the spread of SARS-CoV-2 and olfactory cell lineage impairment in close-contact infection Syrian hamster models
Ueha R, Ito T, Ueha S, Furukawa R, Kitabatake M, Ouji-Sageshima N, Uranaka T, Tanaka H, Nishijima H, Kondo K, Yamasoba T |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
Kwon HJ, Kosikova M, Tang W, Ortega-Rodriguez U, Radvak P, Xiang R, Mercer KE, Muskhelishvili L, Davis K, Ward JM, Kosik I, Holly J, Kang I, Yewdell JW, Plant EP, Chen WH, Shriver MC, Barnes RS, Pasetti MF, Zhou B, Wentworth DE, Xie H |
iScience | 2022 |
|
Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters
Liu S, Stauft CB, Selvaraj P, Chandrasekaran P, D\u2019Agnillo F, Chou CK, Wu WW, Lien CZ, Meseda CA, Pedro CL, Starost MF, Weir JP, Wang TT |
Nature Communications | 2022 |
|
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
Péricat D, Leon-Icaza SA, Sanchez Rico M, Mühle C, Zoicas I, Schumacher F, Planès R, Mazars R, Gros G, Carpinteiro A, Becker KA, Izopet J, Strub-Wourgaft N, Sjö P, Neyrolles O, Kleuser B, Limosin F, Gulbins E, Kornhuber J, Meunier E, Hoertel N, Cougoule C |
International journal of molecular sciences | 2022 |
|
Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
Toomer G, Burns W, Garcia L, Henry G, Biancofiori A, George A, Duffy C, Chu J, Sides M, Muñoz M, Garcia K, Nikolai-Yogerst A, Peng X, Westfall L, Baker R |
Viruses | 2022 |
|
Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
Kim SH, Kim J, Jang JY, Noh H, Park J, Jeong H, Jeon D, Uhm C, Oh H, Cho K, Jeon Y, On D, Yoon S, Lim SY, Kim SP, Lee YW, Jang HJ, Park IH, Oh J, Seo JS, Kim JJ, Seok SH, Lee YJ, Hong SM, An SH, Kim SY, Kim YB, Hwang JY, Lee HJ, Kim HB, Choi KS, Park JW, Seo JY, Yun JW, Shin JS, Lee HY, Kim K, Lee D, Lee H, Nam KT, Seong JK |
Frontiers in immunology | 2022 |
|
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
Venzon M, Bernard-Raichon L, Klein J, Axelrad JE, Zhang C, Hussey GA, Sullivan AP, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E, Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J |
bioRxiv : the preprint server for biology | 2022 |
|
Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron
Chong Z, Karl CE, Halfmann PJ, Kawaoka Y, Winkler ES, Yu J, Diamond MS |
2022 |
